Shawn Singh - 28 Jun 2024 Form 4 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Cynthia Anderson, Attorney-in-Fact
Issuer symbol
VTGN
Transactions as of
28 Jun 2024
Net transactions value
+$14,358
Form type
4
Filing time
02 Jul 2024, 18:06:41 UTC
Previous filing
26 Jun 2024
Next filing
25 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $14,358 +4,854 +86% $2.96 10,487 28 Jun 2024 Direct F1
holding VTGN Common Stock 20,875 28 Jun 2024 By The 1997 Singh Family Trust U/R/D 05/29/97
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended.